The straight and narrow: A game theory model of broadand narrow-spectrum empiric antibiotic therapy

被引:1
|
作者
Diamant, Maya [1 ,2 ,3 ]
Obolski, Uri [2 ,3 ]
机构
[1] Tel Aviv Univ, Coller Sch Management, Tel Aviv, Israel
[2] Tel Aviv Univ, Sch Publ Hlth, Tel Aviv, Israel
[3] Tel Aviv Univ, Porter Sch Environm & Earth Sci, IL-6997801 Tel Aviv, Israel
基金
以色列科学基金会;
关键词
Antibiotics; Antibiotic resistance; Game theory; Medical decision making; Social dilemma; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; RESISTANCE; ASSOCIATION; MANAGEMENT;
D O I
10.1016/j.mbs.2024.109203
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Physicians prescribe empiric antibiotic treatment when definitive knowledge of the pathogen causing an infection is lacking. The options of empiric treatment can be largely divided into broadand narrow-spectrum antibiotics. Prescribing a broad-spectrum antibiotic increases the chances of covering the causative pathogen, and hence benefits the current patient's recovery. However, prescription of broad-spectrum antibiotics also accelerates the expansion of antibiotic resistance, potentially harming future patients. We analyse the social dilemma using game theory. In our game model, physicians choose between prescribing broad and narrow- spectrum antibiotics to their patients. Their decisions rely on the probability of an infection by a resistant pathogen before definitive laboratory results are available. We prove that whenever the equilibrium strategies differ from the socially optimal policy, the deviation is always towards a more excessive use of the broadspectrum antibiotic. We further show that if prescribing broad-spectrum antibiotics only to patients with a high probability of resistant infection is the socially optimal policy, then decentralization of the decision making may make this policy individually irrational, and thus sabotage its implementation. We discuss the importance of improving the probabilistic information available to the physician and promoting centralized decision making.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Design and Electroluminescence Properties of Narrow-spectrum Phosphorescent Complexes
    Zhang Huidong
    Gu Panpan
    Zhang Fang
    Du Mingxu
    Ye Kaiqi
    Liu Yu
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2021, 42 (12): : 3571 - 3578
  • [22] Narrow-Spectrum Antibacterial Agents-Benefits and Challenges
    Alm, Richard A.
    Lahiri, Sushmita D.
    ANTIBIOTICS-BASEL, 2020, 9 (07):
  • [23] Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile
    Xinyun Cao
    Hande Boyaci
    James Chen
    Yu Bao
    Robert Landick
    Elizabeth A. Campbell
    Nature, 2022, 604 : 541 - 545
  • [24] Profiling the effects of acne therapeutics, including the novel narrow-spectrum antibiotic sarecycline, on the human microbiota
    Moura, I.
    Spittal, W.
    Clark, E.
    Ewin, D.
    Altringham, J.
    Fumero, E.
    Grada, A.
    Wilcox, M.
    Buckley, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S187 - S187
  • [25] Revised hospital antibiotic formulary reduces antimicrobial consumption and promotes a shift towards narrow-spectrum antibiotic usage
    Zamami, Taketo
    Shiohira, Hideo
    Nakamatsu, Masashi
    Nishiyama, Naoya
    Tateyama, Masao
    Fujita, Jiro
    Nakamura, Katsunori
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021,
  • [26] BROAD VERSUS NARROW-SPECTRUM HERBICIDES AND THE FUTURE OF MIXTURES
    MARTIN, TJ
    PESTICIDE SCIENCE, 1987, 20 (04): : 289 - 299
  • [27] Imaging Through Fire Using Narrow-Spectrum Illumination
    Smith, Christopher M.
    Hoehler, Matthew S.
    FIRE TECHNOLOGY, 2018, 54 (06) : 1705 - 1723
  • [28] Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile
    Cao, Xinyun
    Boyaci, Hande
    Chen, James
    Bao, Yu
    Landick, Robert
    Campbell, Elizabeth A.
    NATURE, 2022, 604 (7906) : 541 - +
  • [29] NARROW-SPECTRUM SEMICONDUCTOR-LASER FROM HITACHI
    不详
    PHOTONICS SPECTRA, 1993, 27 (08) : 29 - 29
  • [30] Antibiotic Treatment Pipeline for Clostridioides difficile Infection (CDI): A Wide Array of Narrow-Spectrum Agents
    T. J. Carlson
    A. J. Gonzales-Luna
    Current Infectious Disease Reports, 2020, 22